Ampreloxetine
A norepinephrine reuptake inhibitor
{{Drugbox
| verifiedfields = changed
| verifiedrevid = 477002123
| image =
| image2 = | IUPAC_name = (1R,2R)-2-[(2-{[2-(2,3-dihydro-1H-inden-2-yl)ethyl]amino}ethyl)amino]-1-phenylethanol | tradename = | legal_status = Investigational | routes_of_administration = Oral | bioavailability = | protein_bound = | metabolism = | elimination_half-life = | excretion = | CAS_number = 123456-78-9 | ATC_prefix = | ATC_suffix = | PubChem = 12345678 | DrugBank = | ChemSpiderID = 123456 | UNII = | KEGG = | ChEBI = | ChEMBL = | synonyms = TD-9855 }}
Ampreloxetine is a norepinephrine reuptake inhibitor (NRI) that is being investigated for the treatment of neurogenic orthostatic hypotension (nOH). It is a selective inhibitor of the norepinephrine transporter, which increases the levels of norepinephrine in the synaptic cleft and enhances sympathetic nervous system activity.
Mechanism of Action[edit | edit source]
Ampreloxetine works by inhibiting the reuptake of norepinephrine (NE) into presynaptic neurons. This action increases the concentration of norepinephrine in the synaptic cleft, thereby enhancing adrenergic signaling. The increased norepinephrine levels lead to vasoconstriction and an increase in blood pressure, which is beneficial in conditions like neurogenic orthostatic hypotension where blood pressure regulation is impaired.
Clinical Development[edit | edit source]
Ampreloxetine is currently in clinical trials for the treatment of neurogenic orthostatic hypotension, a condition characterized by a significant drop in blood pressure upon standing, leading to dizziness and fainting. The drug is being developed by Theravance Biopharma and has shown promise in early-phase clinical trials.
Pharmacokinetics[edit | edit source]
The pharmacokinetic profile of ampreloxetine includes oral administration, with studies indicating a favorable absorption and distribution profile. The elimination half-life of ampreloxetine allows for once-daily dosing, which is advantageous for patient compliance.
Potential Side Effects[edit | edit source]
As with other norepinephrine reuptake inhibitors, potential side effects of ampreloxetine may include increased heart rate, hypertension, and insomnia. These effects are due to the increased adrenergic activity resulting from higher norepinephrine levels.
Research and Future Directions[edit | edit source]
Research is ongoing to determine the long-term efficacy and safety of ampreloxetine in patients with neurogenic orthostatic hypotension. Future studies may explore its use in other conditions associated with dysregulated norepinephrine levels.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD